162 related articles for article (PubMed ID: 21536114)
1. Functionalization of lactose as a biological carrier for bovine serum albumin by electrospraying.
Tavares Cardoso MA; Talebi M; Soares PA; Yurteri CU; van Ommen JR
Int J Pharm; 2011 Jul; 414(1-2):1-5. PubMed ID: 21536114
[TBL] [Abstract][Full Text] [Related]
2. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
3. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations.
Adi H; Traini D; Chan HK; Young PM
J Pharm Sci; 2008 Jul; 97(7):2780-8. PubMed ID: 17894369
[TBL] [Abstract][Full Text] [Related]
4. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
Int J Pharm; 2006 Dec; 327(1-2):17-25. PubMed ID: 16920287
[TBL] [Abstract][Full Text] [Related]
5. Development of inhalable dry powder formulation of basic fibroblast growth factor.
Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
[TBL] [Abstract][Full Text] [Related]
6. Effect of milling and sieving on functionality of dry powder inhalation products.
Steckel H; Markefka P; teWierik H; Kammelar R
Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
[TBL] [Abstract][Full Text] [Related]
7. Effect of particle morphology on the triboelectrification in dry powder inhalers.
Murtomaa M; Mellin V; Harjunen P; Lankinen T; Laine E; Lehto VP
Int J Pharm; 2004 Sep; 282(1-2):107-14. PubMed ID: 15336386
[TBL] [Abstract][Full Text] [Related]
8. Scanning white-light interferometry as a novel technique to quantify the surface roughness of micron-sized particles for inhalation.
Adi S; Adi H; Chan HK; Young PM; Traini D; Yang R; Yu A
Langmuir; 2008 Oct; 24(19):11307-12. PubMed ID: 18759384
[TBL] [Abstract][Full Text] [Related]
9. Particle formation of budesonide from alcohol-modified subcritical water solutions.
Carr AG; Mammucari R; Foster NR
Int J Pharm; 2011 Feb; 405(1-2):169-80. PubMed ID: 21129462
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Bovine Serum Albumin (BSA) nanoparticles by desolvation using a membrane contactor: a new tool for large scale production.
Yedomon B; Fessi H; Charcosset C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):398-405. PubMed ID: 23811438
[TBL] [Abstract][Full Text] [Related]
11. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers.
Flament MP; Leterme P; Gayot A
Int J Pharm; 2004 May; 275(1-2):201-9. PubMed ID: 15081150
[TBL] [Abstract][Full Text] [Related]
12. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.
Bhavna ; Ahmad FJ; Mittal G; Jain GK; Malhotra G; Khar RK; Bhatnagar A
Eur J Pharm Biopharm; 2009 Feb; 71(2):282-91. PubMed ID: 18984050
[TBL] [Abstract][Full Text] [Related]
13. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
Dhumal RS; Biradar SV; Paradkar AR; York P
Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
15. Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems.
Ooi J; Traini D; Hoe S; Wong W; Young PM
Int J Pharm; 2011 Jul; 413(1-2):1-9. PubMed ID: 21501674
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
[TBL] [Abstract][Full Text] [Related]
17. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy.
Lee SH; Heng D; Ng WK; Chan HK; Tan RB
Int J Pharm; 2011 Jan; 403(1-2):192-200. PubMed ID: 20951781
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of electrospraying fully aqueous bovine serum albumin solutions.
Batens M; Dewaele L; Massant J; Teodorescu B; Clasen C; Van den Mooter G
Eur J Pharm Biopharm; 2020 Feb; 147():102-110. PubMed ID: 31899368
[TBL] [Abstract][Full Text] [Related]
19. Protein micro and nanoencapsulation within glycol-chitosan/Ca²+/alginate matrix by spray drying.
Erdinc B; Neufeld RJ
Drug Dev Ind Pharm; 2011 Jun; 37(6):619-27. PubMed ID: 21449696
[TBL] [Abstract][Full Text] [Related]
20. The influence of formulation components on the aerosolisation properties of spray-dried powders.
Rabbani NR; Seville PC
J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
